Cardiac electrophysiological modulation by NS-7, a novel neuroprotective drug, of guinea pig ventricular muscles

Life Sciences

Volumn 72, Issue 9, 2003, Pages 1039-1048

  Satoh, Hiroyasu ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

293B; Action potential; Ca dependent; E 4031; Frequency dependent; Guinea pig ventricular cells; Neuroprotective drug; NS 7

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; 4 (4 FLUOROPHENYL) 2 METHYL 6 (5 PIPERIDINOPENTYLOXY)PYRIMIDINE; CALCIUM ION; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXTRACELLULAR CALCIUM; GUINEA PIG; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE; HEART MUSCLE POTENTIAL; HEART PROTECTION; HEART REPOLARIZATION; HEART VENTRICLE WALL; MEMBRANE STEADY POTENTIAL; MICROELECTRODE; NEUROPROTECTION; NONHUMAN; STIMULATION; TIME;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CALCIUM; CHROMANS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ELECTRIC STIMULATION; GUINEA PIGS; HEART VENTRICLES; NEUROPROTECTIVE AGENTS; PAPILLARY MUSCLES; PIPERIDINES; POTASSIUM CHANNEL BLOCKERS; PYRIDINES; PYRIMIDINES; SULFONAMIDES;

CAVIA PORCELLUS; SUS SCROFA;

EID: 0037449369     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02359-7     Document Type: Article

References (28)

1. Takagaki Y., Itoh Y., Aoki Y., Ukai Y., Yoshikuni Y., Kimura K. Inhibition of ischemia-induced fodrin breakdown by a novel phenylpyrimidine derivative NS-7: an implication for its neuroprotective action in rats with middle cerebral artery occlusion. J. Neurochem. 68:1997;2507-2513.
2. Aoki Y., Tamura M., Itoh Y., Seto T., Nonaka K., Mukai H., Ukai Y. Cerebroprotective effects of NS-7, a novel pyrimidine derivative, in rats after permanent middle cerebral artery occlusion. J. Pharmacol. Exp. Ther. 296:2001;306-311.
3. 2+ channel blocker NS-7 I. Effect on the cerebral infarction and edema at the acute stage of permanent middle cerebral artery occlusion in rats. Brain Res. 890:2001;162-169.
4. 2+ channel blocker NS-7 II. Effect on the cerebral infraction, behavioral and cognitive impairments at the chronic stage of permanent middle cerebral artery occlusion in rats. Brain Res. 890:2001;170-176.
5. 2+ channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia. J. Cereb. Blood Flow Metab. 14:1994;903-910.
6. + channels as targets for neuroprotective drugs. Trends Pharmacol. Sci. 16:1995;309-316.
7. Szatkowski M., Barbour B., Attwell D. Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature. 348:1990;443-446.
8. Kanai Y., Smith C.P., Hediger M.A. A new family of neurotransmitter transporters: the high-affinity glutamate transporters. FASEB J. 7:1993;1450-1459.
9. Kiedrowski L., Wroblewski J.T., Costa E. Intracellular sodium concentration in cultured cerebellar granule cells challenged with glutamate. Mol. Pharmascol. 45:1994;1050-1054.
10. Koch R.A., Barish M.E. Pertubation of intracellular calcium and hydrogen ion regulation in cultured mouse hippocampal neurons by reduction of the sodium ion concentration gradient. J. Neurosci. 14:1994;2585-2593.
11. 2+ channel blocking actions of NS-7, a novel neuroprotective agent, in NG108-15 cells. Eur. J. Pharmacol. 336:1997;283-290.
12. 2+ channels involving depolarization-stimulated nitric oxide synthase activity in primary neuronal culture. J. Neurochem. 72:1999;1315-1322.
13. Satoh H. Modulation by a novel neuroprotective agent (NS-7) of cardiac ion currents. Jpn. J. Pharmacol. 79(SI):1999;175P.
14. Ks in guinea pig ventricular cardiomyocytes. Br. J. Pharmacol. 126:1999;87-92.
15. Satoh H., Tsuchida K., Hashimoto K. Electrophysiological actions of A23187 and X-537A in spontaneously beating and in voltage-clamped rabbit sino-atrial node preparations. Naunyn-Schmiedeberg's Arch. Pharmacol. 339:1989;320-326.
16. + current. J. Gen. Physiol. 96:1990;195-215.
17. Ks in guinea pig cardiac myocytes and guinea pig IsK channels by the chromanol 293B. Pflüger Arch. 432:1996;1094-1096.
18. + current, on repolarization in human and guinea pig ventricular myocytes. Cardiovasc. Res. 38:1998;441-450.
19. Shimizu T., Itoh Y., Tatsumi S., Hayashi S., Ukai Y., Yoshikuni Y., Kimura K. Blockade of voltage-sensitive sodium channels by NS-7, a nevel neuroprotective compound, in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 355:1997;601-608.
20. ks currents in rat sino-atrial nodal cells. Eur. J. Pharmacol. 407:2000;123-129.
21. Satoh H., Hashimoto K. An electrophysiological study of amiloride on sino-atrial node cells and ventricular muscle of rabbit and dog. Naunyn-Schmiedeberg's Arch. Pharmacol. 333:1986;83-90.
22. Satoh H., Ishii M., Hashimoto K. An electrophysiological comparison between a novel class Ic antiarrhythmic agent, NIK-244 (ethacizin), and flecainide in canine ventricular muscle. Br. J. Pharmacol. 98:1989;827-832.
23. Satoh H., Vassalle M. Role of calcium in caffeine-norepinephrine interactions in canine Purkinje fibers. Am. J. Physiol. 257:1989;H226-H237.
24. Nario K., Satoh H. Cardiac mechanical and electrophysiologic modulations of guinea pig by caffeine and thapsigargin. Gen. Pharmacol. 27:1996;1227-1235.
25. Satoh H. Comparative electrophysiological and mechanical actions of ATP-sensitive potassium channel openers in canine Purkinje fibers. Gen. Pharmacol. 24:1993;565-575.
26. 2+-dependence of caffeine modulation of the rate-force relation in canine cardiac Purkinje fibers. J. Pharmacol. Exp. Ther. 278:1996;826-835.
27. 2+ channel blocker, NS-7, suppresses hypoxic injury in rat cerebrocortical slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;191-196.
28. 2+ channel blocker NS-7 inhibits evoked but not spontaneous dopamine release from rat striatum, as measured by intracerebral microdialysis. Neurosci. Lett. 252:1998;203-206.